POHER II: Early Ultrasound Screening of Heterotopic Ossification After Severe Neurological Trauma

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04934332
Collaborator
Fondation Paul Bennetot (Other)
80
1
1
22
3.6

Study Details

Study Description

Brief Summary

Prospective, bi-centric diagnostic, performance study on a new diagnostic procedure with ultrasounds against a reference diagnostic procedure.

The primary objective is to study the performance of ultrasound coupled with clinical examination at 1 week of admission for early screening of heterotopic ossification (HO) in patients admitted to a post intensive care rehabilitation unit (PICRU) after a severe neurologic trauma.

The CT scan at 5 weeks of admission is considered as the gold standard. CT scan reader will be blinded to clinical data.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ultrasound
  • Procedure: CT scan
  • Procedure: Clinical examination
N/A

Detailed Description

Heterotopic ossification still pose the problem of diagnosis and clinical management that is too late and invasive when complications arise. The challenge would be to identify patients at earlier stage of HO development in order to start an early treatment. This study will focus on the performance of ultrasound in the early screening of HO for patients admitted to a post intensive care rehabilitation unit after severe neurological trauma, this population being at high risk of HO.

Patient enrollment will be performed only at the PICRU of the Raymond Poincaré Hospital (AP-HP). Another center (the imaging department of the same hospital) will participate in this research for ultrasounds and CT scans, but will not perform any recruitment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Early Ultrasound Screening of Heterotopic Ossification After Severe Neurological Trauma in a Post-intensive Care Rehabilitation Unit
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Newly hospitalized patients

Patients admitted for the first time to a post intensive care rehabilitation unit after severe neurological trauma.

Procedure: Ultrasound
Ultrasound examination at 1 week and 5 weeks after admission.

Procedure: CT scan
CT scan at 5 weeks after admission. CT scan reader will be blinded to clinical data.

Procedure: Clinical examination
Weekly clinical examination from week-2 to week-5.

Outcome Measures

Primary Outcome Measures

  1. Area under the ROC (receiver operating characteristic) curve at 1 week [at 1 week]

    Area under the ROC curve of ultrasound examination at 1 week compared CT scan at 5 weeks for making the diagnosis of HO.

Secondary Outcome Measures

  1. Sensitivity [at 1 week]

    Sensitivity of ultrasound examination at 1 week for making the diagnosis of HO, the CT scan at 5 weeks of admission being considered as the gold standard.

  2. Specificity [at 1 week]

    Specificity of ultrasound examination at 1 week for making the diagnosis of HO, the CT scan at 5 weeks of admission being considered as the gold standard.

  3. Positive predictive value and negative predictive value [at 1 week]

    Positive predictive value and negative predictive value of ultrasound examination at 1 week for making the diagnosis of HO, the CT scan at 5 weeks of admission being considered as the gold standard.

  4. Likelihood-ratio of ultrasound [at 1 week]

    Likelihood-ratio of ultrasound examination at 1 week for making the diagnosis of HO, the CT scan at 5 weeks of admission being considered as the gold standard.

  5. Area under the ROC curve at 5 weeks [at 5 weeks]

    Area under the ROC curve of ultrasound examination at 5 weeks compared with CT scan at 5 weeks for making the diagnosis of HO.

  6. Clinical examination [weekly from week-1 to week-5]

    Area under the ROC curve of clinical examination at 1, 2, 3, 4, 5 weeks of admission compared with CT scan at 5 weeks to screen HO.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients ⩾ 18 years;

  • Admitted to a neurological post intensive care rehabilitation unit for the first time;

  • Hospitalized in ICU before being admitted to PICRU for a for traumatic brain injury (initial Glasgow coma scale < 14 and brain radiological abnormalities at the time of admission to ICU and / or a traumatic spinal cord injury (para- or tetraplegia with at least half of key muscles of the 2019 ISNCSCI classification with a strength of less than 3 below the neurological level of the injury at the time of admission to PICRU);

  • Patient's written consent obtained (or from an authorized relative);

  • Affiliation to a social security scheme.

Exclusion Criteria:
  • History of moderate or severe traumatic brain injury;

  • History of spinal cord injury (para- or tetraplegia);

  • History of stroke or disabling neurological disease;

  • History of hospitalization in neurological or neurosurgical or traumatological ICU for another reason;

  • Breast-feeding or pregnancy;

  • Under court protection.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP Garche France 92380

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris
  • Fondation Paul Bennetot

Investigators

  • Principal Investigator: Julie PAQUEREAU, MD, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France
  • Study Director: Vincent T. CARPENTIER, MD, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT04934332
Other Study ID Numbers:
  • APHP210785
  • IDRCB 2021-A01096-35
First Posted:
Jun 22, 2021
Last Update Posted:
Feb 23, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 23, 2022